Adrenomyeloneuropathy and Adrenoleukodystrophy
Adrenoleukodystrophy (ALD) is a genetic condition that leads to myelin damage. It has an estimated prevalence of 1 in 20,000 individuals. ALD typically develops during childhood and can lead to symptoms such as:
- Adrenal gland dysfunction (Addison’s disease)
- Vision or hearing loss
- Impaired coordination and movement
- Changes in behavior, such as withdrawal or aggression
- Problems with memory and learning
- Difficulty with speech
- Swallowing difficulties
- Seizures
Adrenomyeloneuropathy (AMN) is similar to ALD in that it’s the same mutation that causes it. Although AMN is more common in adults, begins within the ages of 21 and 35 years, and includes symptoms such as:
- Progressive weakness or stiffness in the legs
- Impaired coordination and movement
- Bladder and bowel problems
- Sexual dysfunction
- Adrenal gland dysfunction (addison’s disease)
- peripheral neuropathy [5]